Name: Name:2-(2-(3-Chloro-2-methylphenylsulfonamido)thiazol-4-yl)-n,n-diethylacetamide
Brand: Angene
SKU: AG00CJIW
Rating: 90 (10 reviews)

2-(2-(3-Chloro-2-methylphenylsulfonamido)thiazol-4-yl)-n,n-diethylacetamide

CAS No.:

376638-65-2

Catalog Number:

AG00CJIW

Molecular Formula:

C16H20ClN3O3S2

Molecular Weight:

401.9313

Pack Size

Purity

Availability

Location

Price(USD)

Quantity

5mg

98%

1 week

United States

$223

- +

10mg

98%

1 week

United States

$307

- +

50mg

98%

1 week

United States

$807

- +

100mg

98%

1 week

United States

$1140

- +

Product Description

Catalog Number:

AG00CJIW

Chemical Name:

2-(2-(3-Chloro-2-methylphenylsulfonamido)thiazol-4-yl)-n,n-diethylacetamide

CAS Number:

376638-65-2

Molecular Formula:

C16H20ClN3O3S2

Molecular Weight:

401.9313

MDL Number:

MFCD25976913

IUPAC Name:

2-[2-[(3-chloro-2-methylphenyl)sulfonylamino]-1,3-thiazol-4-yl]-N,N-diethylacetamide

InChI:

InChI=1S/C16H20ClN3O3S2/c1-4-20(5-2)15(21)9-12-10-24-16(18-12)19-25(22,23)14-8-6-7-13(17)11(14)3/h6-8,10H,4-5,9H2,1-3H3,(H,18,19)

InChI Key:

PNFMZAHWOASGJC-UHFFFAOYSA-N

SMILES:

CCN(C(=O)Cc1csc(n1)NS(=O)(=O)c1cccc(c1C)Cl)CC

Properties

Complexity:

551

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

401.063g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

401.924g/mol

Monoisotopic Mass:

401.063g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

116A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

Literature

Title	Journal
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors.	Bioorganic & medicinal chemistry letters 20100301
Blockade of glucocorticoid excess at the tissue level: inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 as a therapy for type 2 diabetes.	Journal of medicinal chemistry 20080828
Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.	Journal of medicinal chemistry 20020829